GTSF1L
Gametocyte-specific factor 1-like
Also known as: C20orf65, dJ1028D15.4, FAM112A, GTSFL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H1H1
- Gene
- GTSF1L
- Ensembl
- ENSG00000124196
- Chromosome
- 20
- Canonical length
- 148 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoli
OverviewNCBI Gene
Predicted to enable zinc ion binding activity. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
148 residues, UniProt reviewed canonical sequence.
>Q9H1H1|GTSF1L
1 MEPEAFEICP YDPHHRIPLS RFQYHLASCR RKNPKKAKKM ATCKYNACHV VPIKNLEEHE
61 AVCVNRSAVE EEDTENPLKV SPPSSEQNDD TQQVSPCLPS PDIWNVDGAN CQHVFVLKTF
121 FPQKVVCEND TKESARETSP QKILRPGQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GTSF1L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 211 nTPM
Expression across tissuesHPA
Tissue
- testis: 211 nTPM
- lymph node: 1.4 nTPM
- tonsil: 1.1 nTPM
- spleen: 0.7 nTPM
- appendix: 0.3 nTPM
- small intestine: 0.3 nTPM
Single-cell type
- late spermatids: 5,894 nCPM
- early spermatids: 3,313 nCPM
- late primary spermatocytes: 746 nCPM
- sertoli cells: 19 nCPM
- leydig cells: 8.4 nCPM
- peritubular myoid cells: 6.2 nCPM
Immune cell
- T-reg: 4 nTPM
- memory B-cell: 0.8 nTPM
- naive B-cell: 0.6 nTPM
- memory CD8 T-cell: 0.5 nTPM
- memory CD4 T-cell: 0.3 nTPM
- naive CD4 T-cell: 0.3 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.79
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.09
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GTSF1L as an antibody target. Whether an autoantibody or antibody against GTSF1L could matter depends on whether native GTSF1L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GTSF1L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GTSF1L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...